Back to top

Truist Financial Reaffirms Their Buy Rating on Chemours Company (CC)

In a report released today, Pete Osterland from Truist Financial maintained a Buy rating on Chemours Company, with a price target of $24.00. Accord...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

The Chemours Company (CC)